首页|逐瘀通络汤联合盐酸氟桂利嗪胶囊治疗瘀血阻络型偏头痛的疗效及对血液流变学的影响

逐瘀通络汤联合盐酸氟桂利嗪胶囊治疗瘀血阻络型偏头痛的疗效及对血液流变学的影响

扫码查看
目的 观察逐瘀通络汤联合盐酸氟桂利嗪胶囊治疗瘀血阻络型偏头痛的疗效及对血液流变学的影响.方法 将90 例偏头痛患者按照随机数字表法分为3 组,联合组30 例予逐瘀通络汤联合盐酸氟桂利嗪胶囊治疗,西药组30 例予盐酸氟桂利嗪胶囊治疗,中药组30 例予逐瘀通络汤治疗.3 组均治疗28 天.比较3 组疗效;观察3 组治疗前后血液流变学指标变化;观察3 组治疗前后血清5-羟色胺(5-HT)、内皮素-1(ET-1)、降钙素基因相关肽(CGRP)水平变化;观察3 组治疗前后头痛发作频率、每次头痛持续时间、头痛视觉模拟评分(VAS)变化;观察 3 组不良反应发生情况.结果 联合组总有效率96.67%(29/30),西药组总有效率 76.67%(23/30),中药组总有效率 73.33%(22/30),联合组优于西药组、中药组(P<0.05),西药组与中药组疗效比较差异无统计学意义(P>0.05).3 组治疗后全血黏度(高切)、全血黏度(低切)、血浆黏度均较本组治疗前降低(P<0.05),治疗后联合组全血黏度(高切)、全血黏度(低切)、血浆黏度均低于西药组、中药组(P<0.05),治疗后西药组与中药组全血黏度(高切)、全血黏度(低切)、血浆黏度比较差异均无统计学意义(P>0.05).3 组治疗后 5-HT、ET-1、CGRP水平均较本组治疗前降低(P<0.05),治疗后联合组5-HT、ET-1、CGRP水平均低于西药组、中药组(P<0.05),治疗后西药组 5-HT水平低于中药组(P<0.05),西药组与中药组ET-1、CGRP水平比较差异无统计学意义(P>0.05).3 组治疗后头痛发作频率、每次头痛持续时间、头痛VAS均较本组治疗前降低(P<0.05),治疗后联合组头痛发作频率、每次头痛持续时间、头痛VAS均低于西药组、中药组(P<0.05),西药组每次头痛持续时间低于中药组(P<0.05).3 组不良反应发生率比较差异均无统计学意义(P>0.05).结论 逐瘀通络汤联合盐酸氟桂利嗪胶囊治疗瘀血阻络型偏头痛,可改善患者血液流变学,调节患者血清5-HT、ET-1、CGRP水平,减轻患者头痛发作情况.
Effects of Zhuyu Tongluo Decoction combined with flunarizine on hemorheology indexes in migraine patients of blood stasis blocking collaterals type
Objective To explore the clinical effect of Zhuyu Tongluo Decoction combined with flunarizine on hemorheo-logy indexes in migraine patients of blood stasis blocking collaterals type.Methods A total of 90 migraine patients were ran-domized 1:1:1 to receive flunarizine(Western medicine[WM]group),Zhuyu Tongluo Decoction(traditional Chinese medicine[TCM]group),or Zhuyu Tongluo Decoction combined with flunarizine(combined group).The treatment was performed for 28 days,aiming to compare curative effects,hemorheology indexes including the levels of 5-hydroxytryptamine(5-HT),endo-thelin-1(ET-1)and calcitonin gene-related peptide(CGRP),as well as headache frequency,headache duration and visual analogue scale(VAS)-headache in the three groups before and after treatment.The incidence of adverse reactions was as-sessed.Results The total effective rate of the combined group was better than that of the WM group and the TCM group(96.67%[29/30]vs 76.67%[23/30]vs 73.33%[22/30],P<0.05).There was no significant difference between WM group and TCM group(P>0.05).After treatment,the whole blood viscosity at high and low shear rates and plasma viscosity in the three groups were significantly lower than those before treat-ment(P<0.05),which in the combined group were more lower than those in the WM group and TCM group(P<0.05),but difference was no significant between WM group and TCM group(P>0.05).The levels of 5-HT,ET-1 and CGRP in the three groups were significantly lower than those before treatment(P<0.05),which in the combined group were more lower than those in WM group and TCM group(P<0.05).The level of 5-HT in WM group was significantly lower than that in TCM group(P<0.05),while there was no significant difference in the levels of ET-1 and CGRP between WM group and TCM group(P>0.05).The headache frequency,headache duration and VAS-headache in the three groups were significantly lower than those before treatment(P<0.05),which in the combined group were significantly lower than those in WM group(P<0.05).The headache duration in the WM group was significantly lower than that in TCM group(P<0.05).There was no significant difference in the incidence of adverse reactions among the three groups(P>0.05).Conclusion For migraine patients of blood stasis blocking collaterals type,Zhuyu Tongluo Decoction combined with flunarizine can improve the patient's hemorheology inde-xes,regulate the serum 5-HT,ET-1 and CGRP levels,and reduce headache frequency.

MigraineIntegrative medicine therapy

连捷、曲芳、王丽苇、石岩、杨宇峰

展开 >

辽宁省大连市中西医结合医院神经内科,辽宁 大连 116011

辽宁中医药大学中医临床技能教研室,辽宁 沈阳 110032

偏头痛 中西医结合疗法

大连市中医药科学研究计划(2019)辽宁省中央引导地方科技发展专项

19Z110032019040018-JH6/102

2024

河北中医
河北省医学情报研究所,河北省中医药学会

河北中医

CSTPCD
影响因子:0.951
ISSN:1002-2619
年,卷(期):2024.46(3)
  • 23